Table 1.
Demographic features and baseline parameters of patients in the thymosin and control groups
| Characteristic | Control group (n = 7) | Thymosin group (n = 13) |
|---|---|---|
| Age in years, mean (range) | 42 (31–61) | 47 (33–62) |
| Years since HIV diagnosis, mean (range) | 2·29 (1–4) | 2·15 (1–6) |
| HIV disease stage, number (%) | ||
| B | 1 (14) | 3 (23) |
| C | 6 (86) | 10 (77) |
| Antiretroviral therapy, number (%) | ||
| 2NRTI + PI | 2 (29) | 5 (38) |
| 2NRTI + NNRTI | 1 (13) | 5 (38) |
| 3 NRTI | 2 (29) | 1 (8) |
| Other combination | 2 (29) | 2 (16) |
| Duration of antiretroviral therapy in months, mean (range) | 13 (6–19) | 13 (3–44) |
| HIV viral load, number (%) | ||
| <50 copies/ml | 5 (71) | 10 (77) |
| 50–400 copies/ml | 2 (29) | 3 (23) |
| CD4 cells/ml, median (range) | 94 (66–171) | 102 (36–145) |
| CD8 cells/ml, median (range) | 882 (450–1192) | 920 (350–1022) |